Ethical Considerations for FDA Accelerated Approval
Scholars debate ways to improve FDA’s accelerated approval mechanism.
Should Patents Create Incentives for Failure?
Scholar argues that patents do not—and should not—compensate for the costs of drug development.
Regulating Weight-Loss Drugs and Supplements
Scholars discuss the regulatory landscape surrounding GLP-1 drugs and dietary supplements.
Off-Label Drug Use Liability
Scholar argues that FDA approval should not save drug makers from state-law claims arising from off-label use.
Global Perspectives on Psychedelics Regulation
Experts discuss the benefits and drawbacks of existing regulatory frameworks for psychedelics.
Emergency Use or Overuse?
Experts discuss FDA’s COVID-19 emergency authorizations and how to recalibrate the regulatory mechanism.